Bender, B., Leipold, D. D., Xu, K., Shen, B., Tibbitts, J., & Friberg, L. E. (2014). A Mechanistic Pharmacokinetic Model Elucidating the Disposition of Trastuzumab Emtansine (T-DM1), an Antibody–Drug Conjugate (ADC) for Treatment of Metastatic Breast Cancer. Springer US.

Bender, Brendan, Douglas D. Leipold, Keyang Xu, Ben-Quan Shen, Jay Tibbitts, and Lena E. Friberg. A Mechanistic Pharmacokinetic Model Elucidating the Disposition of Trastuzumab Emtansine (T-DM1), an Antibody–Drug Conjugate (ADC) for Treatment of Metastatic Breast Cancer. Springer US, 2014.

Bender, Brendan, et al. A Mechanistic Pharmacokinetic Model Elucidating the Disposition of Trastuzumab Emtansine (T-DM1), an Antibody–Drug Conjugate (ADC) for Treatment of Metastatic Breast Cancer. Springer US, 2014.